Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASSIST-3: Canfosfamide + Carboplatin in Ovarian Cancer
NCT00102973Phase 3Completed
- Sponsor
- Telik, Inc.
- Start
- Dec 2004
- Primary completion
- Jul 2008
- Modality
- DNA Intercalators/Alkylators, Peptides, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of canfosfamide in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by Telik, Inc.. Started Dec 2004; status: completed.
02
Drugs
canfosfamide
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT00102973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00102973.